Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06653465

Intravenous Acetaminophen for Postoperative Delirium in Older Patients Recovering From Major Noncardiac Surgery

Investigators propose this multi-center randomised controlled study to test the preventive effect of intravenouse acetaminophen in delirium over 5 postoperative days among older patients recovering from major non-cardiac surgery.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

About this study

Delirium is a common complication in elderly patients after major surgeries and can lead to poor outcomes such as neurocognitive decline. Acetaminophen is a widely used adjuvant for perioperative multimodal analgesia. It can effectively alleviate postoperative pain, promote opioid-sparing and exert anti-neuroinflammatory response, showing strong potential for preventing postoperative delirium. There is evidence that intravenous acetaminophen reduces delirium in older patients following cardiac surgery, but its effectiveness is inconclusive among non-cardiac surgical patients. Investigators propose this multi-center, randomized, placebo-controlled, parallel-group trial in patients aged >65 years old scheduled for non-cardiac major surgery with general anesthesia expected to last at least 2 h. A total of 1930 elderly patients will be enrolled and randomized at 1:1 ratio to acetaminophen or saline placebo groups, stratified by age, education level, and trial site with random-sized blocking. Acetaminophen or saline will be given when the surgical suture begin at the end of surgery and thereafter a total of 7 doses within 48h after surgery. The primary outcome will be the incidence of delirium, assessed twice daily, through the five postoperative days. Secondary outcomes will include pain scores with movement, opioid use within the first 48 postoperative hours, severity of delirium, ICU and hospital lengths of stay.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 65 years.
  • Scheduled for non-cardiac major surgery with general anesthesia that is expected to last more than 2h.
  • ASA Physical Status I-III.
  • Weight >50 kg.
  • Written informed consent.

Exclusion criteria

  • Pre-existing neuropsychiatric diseases (Alzheimer's disease, Schizophrenia, Parkinson's Disease, Seizures, etc.).
  • Pre-existing cognitive impairment (MMSE<18).
  • Preoperative delirium.
  • Severe circulatory instability (preoperative left ventricular ejection fraction less than 30%, unstable angina, severe coronary artery disease, sick sinus syndrome, etc.).
  • Contraindication to the acetaminophen use, including serum creatinine > 177µmol/L or aminotransferses > 3 times the upper limit of normal.
  • Alcohol or drug abuse within a year before surgery.
  • Inability to communicate because of severe visual/auditory dysfunction or language barrier.

Treatment and study plan

Acetaminophen

Drug

Acetaminophen, which has similarly effects with NSAIDs in terms of inhibition of cyclooxygenase COX1, COX2 and COX3, is widely used as adjuvant for perioperative multimodal analgesia.

Saline

Drug

Saline, a kind of crystalloid widely used in clinical treatment.

Primary outcomes

  1. Incidence of postoperative delirium

    Time frame: Participants will be followed up during the first 5 postoperative days.

    Delirium will be assessed by the trained investigators twice daily, from 8-10 AM and from 5-7 PM, starting from postoperative day 1 using 3-minute Confusion Assessment Method (3D-CAM) or CAM-ICU for intubated patients. Immediately before assessing delirium, sedation or agitation was assessed using Richmond Agitation-Sedation Scale (RASS). If the patient was too deeply sedated or unarousable (RASS -4 or -5), delirium assessment was aborted and the patient was recorded as comatose.

Secondary outcomes

  1. Delirium type

    Time frame: Participants will be followed up during the first 5 postoperative days.

    Patients with delirium were classified into three motoric subtypes. Hyperactive delirium was defined when RASS was consistently positive (+1 to +4); hypoactive delirium was defined when RASS was consistently neutral or negative (-3 to 0); and mixed delirium was defined when some RASS scores were positive (+1 to +4) and some RASS scores were neutral or negative (-3 to 0).

  2. Delirium severity

    Time frame: Participants will be followed up during the first 5 postoperative days.

    Delirium rating scale 98 revised (DRS-R-98) will be used to evaluate severity of delirium. DRS-R-98 consists of 16 items, including 13 items to assess severity of delirium and 3 diagnostic items. The total severity score range from zero (best) to 39 (worst).

  3. Pain scores

    Time frame: Participants will be followed up during the first 5 postoperative days.

    Pain scores will be assessed using numerical rating scale (NRS) once daily, with 0 meaning "no pain" and 10 meaning "the worst pain imaginable".

  4. Total opioid consumption

    Time frame: Participants will be followed up during the first 5 postoperative days.

    Amount of intravenous and/or oral opioid consumption for analgesia will be recorded.

  5. Delirium duration

    Time frame: Participants will be followed up during the first 5 postoperative days.

    Time to onset of delirium.

Other outcomes

  1. Cognitive function

    Time frame: Cognitive function will be evaluated on the fifth day after operation.

    Cognitive function will be evaluated with Mini-Mental State Examination (MMSE) score that ranges from zero (worst) to 30 (best).

  2. Length of days in ICU and hospital after surgery

    Time frame: one month

    Length of stay in ICU and hospital after surgery will be collected from electronic medical records.

  3. All cause mortality

    Time frame: one month

Study contacts

Contact information is provided by the study sponsor or research team.

LIQUN YANG, MD

CONTACT

[email protected]

15921969001

Sponsors and collaborators

Lead sponsor

RenJi Hospital

Other

Registry information

Official study title

Intravenous Acetaminophen for Postoperative Delirium in Older Patients Recovering From Major Noncardiac Surgery: a Randomised Controlled Study

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Oct 22, 2024
Registry last updated
Apr 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.